Investigating intratumour heterogeneity by single-cell sequencing

Area of Science:

• Oncology
• Genomics
• Biotechnology

Background:

• Intratumour heterogeneity, the diversity of cells within a single tumor, is a critical challenge in cancer research and treatment.
• Current understanding is largely based on the clonal evolution (CE) theory and the cancer stem cell (CSC) model.
• Addressing heterogeneity is crucial for improving early diagnosis, prognosis, and individualized cancer therapy.

Purpose of the Study:

• To evaluate single-cell sequencing (SCS) as a novel technique for investigating intratumour heterogeneity.
• To assess the relevance and application of SCS in both research and clinical settings.
• To highlight the potential of SCS in advancing cancer diagnostics and therapeutics.

Main Methods:

• Review and assessment of single-cell sequencing (SCS) methodologies.
• Analysis of SCS applications in the context of intratumour heterogeneity.
• Consideration of SCS for detecting rare tumor cells and monitoring circulating tumor cells (CTCs).

Main Results:

• Single-cell sequencing (SCS) offers unprecedented resolution for characterizing intratumour heterogeneity.
• SCS facilitates the identification of rare cell populations and the understanding of tumor evolution.
• The technique shows promise for monitoring treatment response and predicting drug resistance.

Conclusions:

• Single-cell sequencing (SCS) is a powerful tool for dissecting intratumour heterogeneity.
• SCS has significant implications for early cancer detection, prognosis prediction, and the development of personalized medicine.
• Further integration of SCS into clinical practice is warranted to improve patient outcomes.